Re: Karl H. Tully, David-Dan Nguyen, Peter Herzog, et al. Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2019.08.003.

Suppr

超能文献

作者信息

Fragkoulis Charalampos, Glykas Ioannis, Papadopoulos Georgios, Ntoumas Konstantinos

机构信息

Department of Urology, G. Gennimatas General Hospital of Athens, Athens, Greece.

出版信息

Eur Urol Oncol. 2020 Dec;3(6):809-810. doi: 10.1016/j.euo.2020.02.002. Epub 2020 Mar 8.

DOI:10.1016/j.euo.2020.02.002

PMID:32156507

Abstract

摘要

相似文献

Re: Karl H. Tully, David-Dan Nguyen, Peter Herzog, et al. Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2019.08.003.

Eur Urol Oncol. 2020 Dec;3(6):809-810. doi: 10.1016/j.euo.2020.02.002. Epub 2020 Mar 8.

Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via Ga-Prostate-specific Membrane Antigen and F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002.

Eur Urol Oncol. 2022 Aug;5(4):475-476. doi: 10.1016/j.euo.2022.04.005. Epub 2022 May 14.

Reply to Ozan Cem Guler and Cem Onal's Letter to the Editor re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via Ga-Prostate-specific Membrane Antigen and F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.04.005.回复奥赞·塞姆·古勒（Ozan Cem Guler）和塞姆·奥纳尔（Cem Onal）致编辑的信：关于潘建、于伟、张廷伟等人的“在雄激素剥夺治疗中早期前列腺特异性抗原进展的非转移性前列腺癌患者中，通过镓-前列腺特异性膜抗原和氟-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描检测到的病变的立体定向放射治疗：一项前瞻性单中心研究”。《欧洲泌尿外科肿瘤学》。即将发表。https://doi.org/10.1016/j.euo.2022.04.005

Eur Urol Oncol. 2022 Aug;5(4):479. doi: 10.1016/j.euo.2022.05.006. Epub 2022 Jun 14.

Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9.回复：利亚姆·伯克、斯蒂芬·吉尔伯特、理查德·胡珀等人。生活方式改变对接受晚期前列腺癌长期雄激素剥夺治疗的久坐男性特定疾病生活质量的改善作用：一项随机对照试验。《欧洲泌尿外科杂志》2014年；65：865 - 872；回复：丹尼尔·A·加尔瓦奥、奈杰尔·斯普里、詹姆斯·德纳姆等人。一项针对接受过雄激素抑制和放疗的前列腺癌男性进行的为期一年的多中心随机对照试验，该试验以运动训练改善身体机能为目标（来自TROG 03.04 RADAR研究）。《欧洲泌尿外科杂志》2014年；65：856 - 864；回复：南希·L·基廷、刘庞祥、A·詹姆斯·奥马利、斯蒂芬·J·弗里德兰、马修·R·史密斯。前列腺癌男性糖尿病患者中的雄激素剥夺治疗与血糖控制。《欧洲泌尿外科杂志》2014年；65：816 - 824；回复：克里斯蒂娜·G·耶斯佩森、梅特·诺尔加德、迈克尔·博勒。前列腺癌治疗中的雄激素剥夺治疗与心肌梗死和中风风险：一项基于丹麦全国人口的队列研究。《欧洲泌尿外科杂志》2014年；65：704 - 709。

Eur Urol. 2014 Sep;66(3):e51-2. doi: 10.1016/j.eururo.2014.04.018. Epub 2014 May 10.

Re: Loren K. Mell, Stephanie L. Pugh, Christopher U. Jones, et al. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.01.020.回复：洛伦·K·梅尔、斯蒂芬妮·L·普格、克里斯托弗·U·琼斯等人。根据竞争事件风险分析雄激素剥夺疗法对前列腺癌预后的影响：一项3期随机试验的二次分析。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2023.01.020

Eur Urol. 2023 Sep;84(3):e73-e74. doi: 10.1016/j.eururo.2023.04.037. Epub 2023 May 17.

Re: Bo Dai, Sheng Zhang, Fan-Ning Wan, et al. Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer : A Phase 2 Randomized Controlled Trial. Eur Urol Oncol 2022;5:519-25.

Eur Urol Oncol. 2023 Aug;6(4):451. doi: 10.1016/j.euo.2023.01.006. Epub 2023 Jan 25.

Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948-54.回复：朗达·L·比廷、帕特里克·希利、丹尼尔·J·乔治等。恩杂鲁胺与雄激素剥夺疗法联合挽救性放疗用于高风险前列腺特异性抗原复发前列腺癌男性患者的II期试验：STREAM试验。《欧洲泌尿外科肿瘤学杂志》2021年；4：948 - 54。

Eur Urol Oncol. 2022 Aug;5(4):477-478. doi: 10.1016/j.euo.2022.03.002. Epub 2022 Mar 17.

Re: Karim A. Touijer, Daniel D. Sjoberg, Nicole Benfante, et al. Limited Versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2021.03.006.

Eur Urol Oncol. 2021 Oct;4(5):852-853. doi: 10.1016/j.euo.2021.07.007. Epub 2021 Sep 15.

Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol 2008;53:941-9 and re: John Anderson. Androgen-deprivation therapy--It's all a matter of timing. Eur Urol 2008;53:869-71.

Eur Urol. 2009 Feb;55(2):e40-2; author reply e45-6. doi: 10.1016/j.eururo.2008.08.039. Epub 2008 Aug 24.

Re: Ost P, Siva S, Brabrand S, et al. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007.

Eur Urol Oncol. 2024 Oct;7(5):1154. doi: 10.1016/j.euo.2024.01.018. Epub 2024 Feb 28.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验